Advancing technology is allowing scientists increasingly to search for tiny signs of cancer and other health issues in samples of patients’ blood and urine. These “liquid biopsies” are less invasive than a traditional biopsy, and can provide information about what’s happening throughout the body instead of just at a single site.
Now researchers have developed a new method for lifting the genetic fingerprints of tiny fragments of RNA found in blood plasma that are invisible to traditional methods of RNA sequencing.
These messenger RNAs and long non-coding RNAs can provide important clues about the activity of genes throughout the body — including genes that are active in particular organs or that are associated with certain diseases, like cancer — and thus could serve as potential biomarkers for a host of conditions.
"The real innovation here was recognizing that these other types of RNA were being missed because they had simple but critical differences that prevented them from showing up in the blood plasma sequencing results,"said the senior author, who published the results in The EMBO Journal.
The new method, called phospho-RNA-seq because of the way the fragment ends are tailored, was first validated in experiments using a curated pool of RNA — so the scientists knew ahead of time what accurate results should look like. Then, to demonstrate that it could work in a real-world setting, the method was tested on plasma samples collected weekly from two patients who underwent bone marrow transplants.
Authors report that plasma contains fragmented mRNAs and lncRNAs that are missed by standard small RNA-seq protocols due to lack of 50 phosphate or presence of 30 phosphate. These fragments were revealed using a modified protocol (“phospho-RNAseq”) incorporating RNA treatment with T4-polynucleotide kinase, which were compared with standard small RNA-seq for sequencing synthetic RNAs with varied 50 and 30 ends, as well as human plasma exRNA.
Analyzing phospho-RNA-seq data using a custom, high-stringency bioinformatic pipeline, authors identified mRNA/lncRNA transcriptome fingerprints in plasma, including tissue-specific gene sets.
In a longitudinal study of hematopoietic stem cell transplant patients, bone marrow- and liver-enriched exRNA genes were tracked with bone marrow recovery and liver injury, respectively, providing proof-of-concept validation as a biomarker approach.
“We could track the markers of the reconstitution of their bone marrow after the transplant, as well as changes in the blood plasma RNA that indicated injury to the liver — which lined up with what we knew was happening from their medical records,” the senior author says.
Phospho-RNA-seq has potential applications for discovery sciences as well as more direct applications, the senior author notes.
“I look at this as proof-of-concept research, but I expect that as we continue to refine the technology and make it even more accessible for other researchers, it’s likely to be applied to many different disease areas and body systems,” the senior author adds.
https://labblog.uofmhealth.org/health-tech/making-invisible-visible-new-method-opens-unexplored-realms-for-liquid-biopsies
http://emboj.embopress.org/content/early/2019/04/30/embj.2019101695
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fphospho-rna-seq-a&filter=22
Latest News
Wiring of the human neocortex
By newseditor
Posted 24 Apr
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Other Top Stories
Turning off autophagy genes in myeloid cells provide protection aga…
Read more
How cells scramble to fix pores formed by microbial attacks
Read more
Modified sugar as a new antiviral treatment
Read more
How malaria parasites import sugar
Read more
Targeting autophagy to treat MERS coronavirus
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Harnessing gastrointestinal…
By newseditor
Posted 24 Apr
Sex-specific modulation of…
By newseditor
Posted 24 Apr
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar